Steven Cohen’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-556,761
Closed -$8.1M – 4544
2026
Q2
$8.1M Buy
556,761
+22,796
+4% +$291K 0.01% 1417
2026
Q1
$8.54M Buy
533,965
+110,550
+26% +$1.5M 0.01% 1352
2025
Q4
$5.16M Buy
+423,415
New +$3.68M 0.01% 1827
2017
Q1
– Sell
-16
Closed -$975K – 958
2016
Q4
$975K Buy
+16
New +$939K 0.01% 607

Other funds holding TENX

Steven Cohen's TENX Position: Q3 2026 in Review

Steven Cohen sold out of Tenax Therapeutics (TENX) in Q3 2026, closing a stake of 556,761 shares — an estimated $8.1M sold.

Steven Cohen first reported a position in TENX in Q4 2016 and held it in 4 quarters. The position peaked at $8.54M in Q1 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

  • Steven Cohen reported no remaining Tenax Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 556,761 Tenax Therapeutics shares in Q3 2026, an estimated $8.1M.
  • Steven Cohen first reported a position in Tenax Therapeutics in Q4 2016 and held it in 4 quarters.
  • Steven Cohen's Tenax Therapeutics position peaked at $8.54M in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.